MediciNova, Inc. (NASDAQ:MNOV)

CAPS Rating No stars 
MNOV VS S&P 500 (SPY)

MNOV News and Commentary

Related News and Articles

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

4 Outperform
0 Underperform
 

All-Star Players

2 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top MNOV Bull/Bear Pitches

zzlangerhans (99.67)
Submitted August 11, 2011

Can MediciNova survive the debt crisis? The answer will likely come in late 2011 or early 2012, when the company reports results of the phase IIb trial of MN-221 in asthma. I'm looking for a run-up play here if the market rebounds, but for CAPS I'll… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Fools bearish on MNOV
are also bearish on:

Featured Broker Partners


Advertisement